This is a news story, published by Gizmodo, that relates primarily to GLP-1s news.
For more GLP-1s news, you can click here:
more GLP-1s newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Gizmodo, you can click here:
more news from GizmodoOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
obesity medications. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss news, incretin drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
massive muscle lossGizmodo
•72% Informative
Semaglutide and tirzepatide are the latest diabetes and obesity medications.
They are the most recent additions to a class of drugs known as incretins, which mimic hormones important to our metabolism and sense of hunger, among other functions.
Some critics have alleged that GLP-1s can dangerously sap our muscle mass.
There is no data to support the notion that weight loss with GLP-1 agonist therapy causes effects on muscle mass, or fat free mass, that lead to abnormalities in physical function.
The lack of data supports massive muscle loss hasn't stopped some drug companies from trying to counteract the issue.
VR Score
60
Informative language
52
Neutral language
46
Article tone
informal
Language
English
Language complexity
49
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
8
Source diversity
6
Affiliate links
no affiliate links